Two of region's anthrax-fighting companies announce merger

Gaithersburg-based immunotherapy company Altimmune Inc. is merging with Annapolis biodefense company PharmAthene Inc. to create a new immunotherapy firm focused on infectious diseases such as anthrax. The merger announced Thursday is an all-stock transaction unanimously approved by both companies' boards. Under the terms, Altimmune will become a wholly owned subsidiary of PharmAthene (NYSE MKT: PIP). Altimmune equity holders will own 58.2 percent of the fully diluted equity of the combined com pany.…
Source: bizjournals.com Health Care News Headlines - Category: Health Management Authors: Source Type: news